Please assess the completion status of the following clinical trial:

Trial Title: Prucalopride Versus Placebo in Gastroparesis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Consecutive patients with a previously established diagnosis of diabetes or functional dyspepsia according to Rome III criteria, and with delayed gastric emptying (t1/2 for solids ≥ 109 min) on a breath test~Exclusion Criteria:~* The presence of oesophagitis, gastric atrophy or erosive gastroduodenal lesions on endoscopy~  * the presence of lesions on small bowel X-ray~ * major abdominal surgery~ * underlying psychiatric illness~ * use of non-steroidal anti-inflammatory drugs, steroids, or drugs affecting gastric motility.~ * Major co-morbidities

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Prucalopride (Type: ACTIVE_COMPARATOR): Prucalopride tablet 2 mg
- Placebo (Type: PLACEBO_COMPARATOR): matching placebo tablet

Based on this trial design, predict the completion outcome and termination type (if applicable).